Dawn Health
PrivateLast Round
Growth Equity
Feb 10, 2026
Total Funding Raised
$50.59M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Dawn Health is a digital health company that specializes in the development of Software as a Medical Device (SaMD) and digital therapeutics for global pharmaceutical companies.
Sector
Healthcare & Life Sciences
Verticals
Patient Engagement, Clinical Trials, Healthcare Analytics, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dawn Health Comparables
Compare Dawn Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrightInsight | 91% | |
| Amalgam Rx | 83% | |
| Alex Therapeutics | 80% |
Dawn Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Feb 10, 2026 | ||||
| VC Round | May 5, 2025 | ||||
| Series A | Dec 1, 2021 |
Key People
Founding team and executive leadership
Dawn Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Chr. Augustinus Fabrikker | VC Round, Growth Equity, Series A |
| The Export and Investment Fund of Denmark | Growth Equity, VC Round, Series A |
| Cipio Partners | Growth Equity |
| Trifork Labs | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 21, 2026
Monthly visitors increased 59% MoM.
- Feb 10, 2026
Raised $26M from Chr. Augustinus Fabrikker, Cipio Partners, and others.
Recent news
Latest coverage and updates
- partners_withOct 21, 2026
Dawn Health partners with Merck & Co on a next-generation digital ecosystem for growth disorders, including a mobile app and HCP portal, in Denmark on May 7th '25.
- is_developingOct 21, 2026
Dawn Health collaborates with Merck, NVIDIA and Microsoft to build an innovative model for Patient Support Programs that supports personalized, continuously available care for patients with rare tumors.
- is_developingOct 21, 2026
Dawn Health collaborates with Merck, NVIDIA and Microsoft to develop a novel support model that uses AI-facilitated technology to make patient support more individualized, responsive and continuously available, with Merck aiming to bring it to patients with desmoid tumors and NF1-PN in Germany on Oct 21st '26.
Dawn Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Dawn Health's valuation, stock price, and market status.
Is Dawn Health a public or private company?
Dawn Health is a private company.
What is the current stock price of Dawn Health?
Dawn Health is a private company, so its shares have no public market price. Caplight tracks Dawn Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dawn Health worth (valuation)?
Valuation information for Dawn Health is not publicly available.
Can I buy Dawn Health stock?
Dawn Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dawn Health's last funding round?
Dawn Health's most recent funding round was Growth Equity on February 10, 2026.
Who are the main investors in Dawn Health?
Key investors in Dawn Health include Chr. Augustinus Fabrikker.
Will Dawn Health IPO soon?
No public IPO plans have been announced for Dawn Health.
How can I track Dawn Health secondary market activity?
Caplight tracks bids, offers, and trades in Dawn Health's shares on secondary markets.